SCHEMBL3603100

SCHEMBL3603100

COC(=O)c1sc(C(=O)O)cc1-c1nnnn1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HIF1A Q16665 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.37
PKM P14618 1/20 0.36
ALDH1A1 P00352 7/20 0.35
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
KDM4E B2RXH2 4/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 1/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603097 0.93 NPC1 (0.41) NPC1RAB9APOLBNPSR1HIF1A
SCHEMBL3612431 0.89 SMN1; SMN2 (0.41) NPSR1HIF1ARXFP1SMN1; SMN2PKM
SCHEMBL3609536 0.78 OPRD1 (0.54) NPC1RAB9ASMN1; SMN2PKMALDH1A1
SCHEMBL3596170 0.77 IKBKB (0.55) NPC1RAB9APOLBNPSR1SMN1; SMN2
SCHEMBL3608687 0.76 MAPK8 (0.42) NPC1POLBSMN1; SMN2PKMALDH1A1
SCHEMBL3596790 0.76 MAPT (0.44) NPC1RAB9ANPSR1HIF1ASMN1; SMN2
SCHEMBL3613774 0.75 HSD11B1 (0.47) NPC1RAB9ANPSR1HIF1ARXFP1
SCHEMBL3613039 0.73 KDM4E (0.43) NPC1RAB9APOLBNPSR1HIF1A
SCHEMBL3602177 0.73 MAPK14 (0.57) NPSR1HIF1ARXFP1ALDH1A1ABCC9
SCHEMBL3615683 0.71 KDM4E (0.44) NPC1RAB9ANPSR1HIF1ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 NPC1 2952/4885RAB9A 3435/4885POLB 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.